Neuropeptide Y in the medial habenula alleviates migraine-like behaviors through the Y1 receptor

Abstract Background Migraine is a highly disabling health burden with multiple symptoms; however, it remains undertreated because of an inadequate understanding of its neural mechanisms. Neuropeptide Y (NPY) has been demonstrated to be involved in the modulation of pain and emotion, and may play a r...

Full description

Bibliographic Details
Main Authors: Chunxiao Yang, Zihua Gong, Xiaochen Zhang, Shuai Miao, Bozhi Li, Wei Xie, Tao Wang, Xun Han, Liang Wang, Zhao Dong, Shengyuan Yu
Format: Article
Language:English
Published: BMC 2023-05-01
Series:The Journal of Headache and Pain
Subjects:
Online Access:https://doi.org/10.1186/s10194-023-01596-z
_version_ 1797817853866409984
author Chunxiao Yang
Zihua Gong
Xiaochen Zhang
Shuai Miao
Bozhi Li
Wei Xie
Tao Wang
Xun Han
Liang Wang
Zhao Dong
Shengyuan Yu
author_facet Chunxiao Yang
Zihua Gong
Xiaochen Zhang
Shuai Miao
Bozhi Li
Wei Xie
Tao Wang
Xun Han
Liang Wang
Zhao Dong
Shengyuan Yu
author_sort Chunxiao Yang
collection DOAJ
description Abstract Background Migraine is a highly disabling health burden with multiple symptoms; however, it remains undertreated because of an inadequate understanding of its neural mechanisms. Neuropeptide Y (NPY) has been demonstrated to be involved in the modulation of pain and emotion, and may play a role in migraine pathophysiology. Changes in NPY levels have been found in patients with migraine, but whether and how these changes contribute to migraine is unknown. Therefore, the purpose of this study was to investigate the role of NPY in migraine-like phenotypes. Methods Here, we used intraperitoneal injection of glyceryl trinitrate (GTN, 10 mg/kg) as a migraine mouse model, which was verified by light-aversive test, von Frey test, and elevated plus maze test. We then performed whole-brain imaging with NPY-GFP mice to explore the critical regions where NPY was changed by GTN treatment. Next, we microinjected NPY into the medial habenula (MHb), and further infused Y1 or Y2 receptor agonists into the MHb, respectively, to detect the effects of NPY in GTN-induced migraine-like behaviors. Results GTN effectively triggered allodynia, photophobia, and anxiety-like behaviors in mice. After that, we found a decreased level of GFP+ cells in the MHb of GTN-treated mice. Microinjection of NPY attenuated GTN-induced allodynia and anxiety without affecting photophobia. Furthermore, we found that activation of Y1—but not Y2—receptors attenuated GTN-induced allodynia and anxiety. Conclusions Taken together, our data support that the NPY signaling in the MHb produces analgesic and anxiolytic effects through the Y1 receptor. These findings may provide new insights into novel therapeutic targets for the treatment of migraine. Graphical Abstract
first_indexed 2024-03-13T08:59:34Z
format Article
id doaj.art-91ffefd6526b494cbc5e2fb55b6fec70
institution Directory Open Access Journal
issn 1129-2377
language English
last_indexed 2024-03-13T08:59:34Z
publishDate 2023-05-01
publisher BMC
record_format Article
series The Journal of Headache and Pain
spelling doaj.art-91ffefd6526b494cbc5e2fb55b6fec702023-05-28T11:23:16ZengBMCThe Journal of Headache and Pain1129-23772023-05-0124112010.1186/s10194-023-01596-zNeuropeptide Y in the medial habenula alleviates migraine-like behaviors through the Y1 receptorChunxiao Yang0Zihua Gong1Xiaochen Zhang2Shuai Miao3Bozhi Li4Wei Xie5Tao Wang6Xun Han7Liang Wang8Zhao Dong9Shengyuan Yu10School of Medicine, Nankai UniversityDepartment of Neurology, the First Medical Center, Chinese PLA General HospitalAcademy of Medical Engineering and Translational Medicine, Tianjin UniversityDepartment of Neurology, the First Medical Center, Chinese PLA General HospitalDepartment of Neurology, the First Medical Center, Chinese PLA General HospitalDepartment of Neurology, the First Medical Center, Chinese PLA General HospitalDepartment of Neurology, the First Medical Center, Chinese PLA General HospitalDepartment of Neurology, the First Medical Center, Chinese PLA General HospitalInstitute of Neuroscience, Zhejiang University School of MedicineSchool of Medicine, Nankai UniversitySchool of Medicine, Nankai UniversityAbstract Background Migraine is a highly disabling health burden with multiple symptoms; however, it remains undertreated because of an inadequate understanding of its neural mechanisms. Neuropeptide Y (NPY) has been demonstrated to be involved in the modulation of pain and emotion, and may play a role in migraine pathophysiology. Changes in NPY levels have been found in patients with migraine, but whether and how these changes contribute to migraine is unknown. Therefore, the purpose of this study was to investigate the role of NPY in migraine-like phenotypes. Methods Here, we used intraperitoneal injection of glyceryl trinitrate (GTN, 10 mg/kg) as a migraine mouse model, which was verified by light-aversive test, von Frey test, and elevated plus maze test. We then performed whole-brain imaging with NPY-GFP mice to explore the critical regions where NPY was changed by GTN treatment. Next, we microinjected NPY into the medial habenula (MHb), and further infused Y1 or Y2 receptor agonists into the MHb, respectively, to detect the effects of NPY in GTN-induced migraine-like behaviors. Results GTN effectively triggered allodynia, photophobia, and anxiety-like behaviors in mice. After that, we found a decreased level of GFP+ cells in the MHb of GTN-treated mice. Microinjection of NPY attenuated GTN-induced allodynia and anxiety without affecting photophobia. Furthermore, we found that activation of Y1—but not Y2—receptors attenuated GTN-induced allodynia and anxiety. Conclusions Taken together, our data support that the NPY signaling in the MHb produces analgesic and anxiolytic effects through the Y1 receptor. These findings may provide new insights into novel therapeutic targets for the treatment of migraine. Graphical Abstracthttps://doi.org/10.1186/s10194-023-01596-zMigraineGlyceryl trinitrateNeuropeptide YY1 receptorMedial habenula
spellingShingle Chunxiao Yang
Zihua Gong
Xiaochen Zhang
Shuai Miao
Bozhi Li
Wei Xie
Tao Wang
Xun Han
Liang Wang
Zhao Dong
Shengyuan Yu
Neuropeptide Y in the medial habenula alleviates migraine-like behaviors through the Y1 receptor
The Journal of Headache and Pain
Migraine
Glyceryl trinitrate
Neuropeptide Y
Y1 receptor
Medial habenula
title Neuropeptide Y in the medial habenula alleviates migraine-like behaviors through the Y1 receptor
title_full Neuropeptide Y in the medial habenula alleviates migraine-like behaviors through the Y1 receptor
title_fullStr Neuropeptide Y in the medial habenula alleviates migraine-like behaviors through the Y1 receptor
title_full_unstemmed Neuropeptide Y in the medial habenula alleviates migraine-like behaviors through the Y1 receptor
title_short Neuropeptide Y in the medial habenula alleviates migraine-like behaviors through the Y1 receptor
title_sort neuropeptide y in the medial habenula alleviates migraine like behaviors through the y1 receptor
topic Migraine
Glyceryl trinitrate
Neuropeptide Y
Y1 receptor
Medial habenula
url https://doi.org/10.1186/s10194-023-01596-z
work_keys_str_mv AT chunxiaoyang neuropeptideyinthemedialhabenulaalleviatesmigrainelikebehaviorsthroughthey1receptor
AT zihuagong neuropeptideyinthemedialhabenulaalleviatesmigrainelikebehaviorsthroughthey1receptor
AT xiaochenzhang neuropeptideyinthemedialhabenulaalleviatesmigrainelikebehaviorsthroughthey1receptor
AT shuaimiao neuropeptideyinthemedialhabenulaalleviatesmigrainelikebehaviorsthroughthey1receptor
AT bozhili neuropeptideyinthemedialhabenulaalleviatesmigrainelikebehaviorsthroughthey1receptor
AT weixie neuropeptideyinthemedialhabenulaalleviatesmigrainelikebehaviorsthroughthey1receptor
AT taowang neuropeptideyinthemedialhabenulaalleviatesmigrainelikebehaviorsthroughthey1receptor
AT xunhan neuropeptideyinthemedialhabenulaalleviatesmigrainelikebehaviorsthroughthey1receptor
AT liangwang neuropeptideyinthemedialhabenulaalleviatesmigrainelikebehaviorsthroughthey1receptor
AT zhaodong neuropeptideyinthemedialhabenulaalleviatesmigrainelikebehaviorsthroughthey1receptor
AT shengyuanyu neuropeptideyinthemedialhabenulaalleviatesmigrainelikebehaviorsthroughthey1receptor